Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $172.9 million.

  • Bio-Techne's Cash & Current Investments fell 436.84% to $172.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $172.9 million, marking a year-over-year decrease of 436.84%. This contributed to the annual value of $165.0 million for FY2025, which is 211.94% up from last year.
  • Latest data reveals that Bio-Techne reported Cash & Current Investments of $172.9 million as of Q4 2025, which was down 436.84% from $145.0 million recorded in Q3 2025.
  • Bio-Techne's Cash & Current Investments' 5-year high stood at $279.0 million during Q4 2021, with a 5-year trough of $140.7 million in Q1 2025.
  • For the 5-year period, Bio-Techne's Cash & Current Investments averaged around $194.1 million, with its median value being $187.5 million (2024).
  • As far as peak fluctuations go, Bio-Techne's Cash & Current Investments plummeted by 3200.0% in 2023, and later soared by 2755.77% in 2024.
  • Quarter analysis of 5 years shows Bio-Techne's Cash & Current Investments stood at $279.0 million in 2021, then decreased by 29.47% to $196.8 million in 2022, then dropped by 27.97% to $141.7 million in 2023, then grew by 27.56% to $180.8 million in 2024, then fell by 4.37% to $172.9 million in 2025.
  • Its Cash & Current Investments was $172.9 million in Q4 2025, compared to $145.0 million in Q3 2025 and $165.0 million in Q2 2025.